Does concomitant treatment with candesartan and metoprolol prevent early decline in global left ventricular function in patients treated for early breast cancer with adjuvant anthracycline-containing regimens?
Concomitant treatment with candesartan protects against early decline in left ventricular function in patients receiving anthracycline-containing regimens for early breast cancer.
In patients treated for early breast cancer with adjuvant anthracycline-containing regimens with or without trastuzumab and radiation, concomitant treatment with candesartan provides protection against early decline in global left ventricular function.
Gulati et al. (Sun,) studied this question.